In summary, we have demonstrated that a partial deficiency of gzmA may slightly ameliorate the progression of ALS disease, which could be explained by an effect on oxidative stress and a dual role of gzmA-mediated inflammation. The gene discussed is GZMA; the disease is amyotrophic lateral sclerosis.